Biotech & Life Sciences
The Partnership That Makes Advanced Cancer Drug Technology Accessible to Smaller Biotech Companies
The cancer drug technology attracting billions in investment just got a significant manufacturing upgrade Antibody-drug conjugates are one of the most exciting and fastest-growing categories in cancer treatment. The concept is elegant: take a highly targeted antibody that seeks out cancer cells specifically, attach a potent cancer-killing drug to it, and deliver that drug precisely…
Why the Insilico Medicine and Lilly Deal Is One of the Most Significant Moments in Pharmaceutical History
When one of the world’s largest pharmaceutical companies writes a check for $115 million upfront and structures a deal worth up to $2.75 billion in total, the industry pays attention. On March 29, 2026, Insilico Medicine (HKEX: 3696) announced a global R&D collaboration with Eli Lilly and Company that grants Lilly an exclusive worldwide license…
Why Sensient’s Project Prism Could Be the Most Important Food Manufacturing Investment of 2026
America is ditching artificial food dyes — and one company just committed $250 million to meet that demand The food industry is in the middle of a colour revolution. For decades, synthetic dyes derived from petroleum have given American food and drinks their vivid colours. That is changing fast. Regulatory pressure, shifting consumer preferences, and…
How Blossom Health Is Getting Americans Into Psychiatric Care Within 48 Hours for $22
America has a psychiatric care crisis — and this AI startup just raised $20 million to fix it Getting a psychiatrist appointment in the United States can take months. In some states, the wait stretches longer. There are simply not enough psychiatrists to meet demand, and the ones who do practise spend enormous amounts of…
China’s Hemophilia A Gene Therapy Partnership That Could Change Everything
Imagine living with a condition where your blood cannot clot properly. Every bump, every minor injury, every joint movement carries the risk of a bleeding episode that could cause permanent damage. For people with severe hemophilia A, that is daily reality. The current standard of care requires regular injections of clotting factor, sometimes every few…
Function Health Connects Your Lab Results to AI — Here’s Why It Matters
Your blood test results just got a lot more useful — if you know how to use them Most people who get lab work done receive a PDF, glance at the numbers, and have no idea what half of them mean. Function Health is trying to change that. On March 20, 2026, the Austin-based health…
GI Innovation and J&J Team Up to Tackle Advanced Prostate Cancer
A small Korean biotech just secured a deal with Johnson & Johnson to tackle one of prostate cancer’s hardest challenges When a company the size of Johnson & Johnson agrees to supply its drug to a clinical trial run by a smaller biotech, it is not a routine transaction. It is a vote of confidence.…
How OPTEL Is Reshaping Pharmaceutical Manufacturing
Pharma factories are leaving capacity on the table — and this AI partnership wants to fix that Two Canadian companies just announced a partnership that could change how pharmaceutical manufacturers plan their production. On March 17, 2026, OPTEL and Kaster Technologies revealed a commercial agreement to bring AI-powered production planning to drug manufacturers worldwide. The…
Why PureHealth Research Focuses on the Liver-Lymph Axis
PureHealth Research Targets the Liver-Lymphatic Connection to Optimize Systemic Detoxification On March 14, 2026, Virginia-based PureHealth Research announced a strategic expansion of its wellness portfolio, focusing on the biological synergy between the liver and the lymphatic system. Moving away from traditional isolated-organ health models, the company is pioneering a systemic approach that addresses how metabolic…
Small Molecules, Big Data: The AI-Powered Future of Oral Obesity Therapies
PRISM BioLab and Receptor.AI Partner to Navigate the Undruggable PPI Landscape On March 12, 2026, Tokyo-based PRISM BioLab and U.S.-based TechBio firm Receptor.AI announced a strategic collaboration to build an integrated, AI-navigated drug discovery platform. This partnership aims to solve one of the most persistent challenges in pharmacology: the discovery of orally available small molecules…
